MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
DarioHealth Corp. DSO Ratio 2011-2025 | DRIO
Annual DSO Ratio DarioHealth Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85.8 | 51 | 12.8 | 82.1 | 34.4 | 11.6 | 30.7 | 37.8 | 9.76 | 236 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 236 | 9.76 | 59.2 |
Quarterly DSO Ratio DarioHealth Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.9 | 49 | 54.1 | - | 71.8 | 107 | 87.5 | - | 121 | 56.5 | 59.5 | - | 52.9 | 56.9 | 33.3 | - | 28.7 | 16.5 | 7.51 | - | 5.54 | 6.33 | 21.8 | - | 32.8 | 37.1 | 17.1 | - | 8.16 | 7.45 | 11.7 | - | 18.7 | 21.3 | 12.8 | - | 28.3 | 30.8 | 41.5 | - | 0.5 | 6.52 | 79 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 121 | 0.5 | 37.4 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
DexCom
DXCM
|
85 | $ 66.7 | -0.39 % | $ 25.7 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 16.71 | 6.1 % | $ 180 M |  China |
 |
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.53 | 0.03 % | $ 18.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.59 | -1.91 % | $ 2.02 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 222.65 | 0.18 % | $ 40.4 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
49.2 | $ 38.47 | -0.41 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
57 | $ 226.5 | 0.08 % | $ 166 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 26.81 | -1.22 % | $ 811 M | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 415.66 | 1.58 % | $ 30 B |  Schweiz |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
51.3 | $ 7.01 | -2.77 % | $ 635 M | USA |
 |
NeoGenomics
NEO
|
77.8 | $ 12.08 | 1.94 % | $ 1.53 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 6.83 | -0.51 % | $ 1.48 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 19.96 | -2.92 % | $ 1.07 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.56 | -0.7 % | $ 114 K | USA |
 |
Co-Diagnostics
CODX
|
101 | $ 0.31 | -9.02 % | $ 9.1 M | USA |
 |
Pacific Biosciences of California
PACB
|
50.4 | $ 2.11 | -0.71 % | $ 535 M | USA |
 |
Quidel Corporation
QDEL
|
116 | $ 28.87 | 0.24 % | $ 1.22 B | USA |
 |
Guardant Health
GH
|
49.2 | $ 104.86 | 2.73 % | $ 12.9 B | USA |
 |
Precipio
PRPO
|
28.1 | $ 24.68 | -1.14 % | $ 32 M | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | $ 45.24 | 0.04 % | $ 10.1 B |  Niderland |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
47.8 | $ 16.81 | -0.15 % | $ 4.75 B | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
Soleno Therapeutics
SLNO
|
33.5 | $ 51.43 | -1.1 % | $ 2.07 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 134.29 | -0.43 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 196.55 | 1.82 % | $ 10.1 B | USA |
 |
Quotient Limited
QTNT
|
45.1 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Thermo Fisher Scientific
TMO
|
69.9 | $ 567.34 | -0.76 % | $ 217 B | USA |
 |
Trinity Biotech plc
TRIB
|
87.2 | $ 1.08 | 0.93 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 31.12 | 0.61 % | $ 1.86 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 183.54 | 0.54 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 7.76 | -1.15 % | $ 1.01 B | USA |